-
Pivotal CRISPR Patent Battle Won By Broad Institute
Sep 10, 2018, 18:10 PM by Michael CroftNature | On 10 September, the US Court of Appeals for the Federal Circuit awarded the pivotal intellectual property to the Broad Institute of Cambridge, Massachusetts, upholding a previous decision by the US Patent and Trademark Office. The decision spells defeat for a team of inventors that includes molecular biologist Jennifer Doudna University of California, Berkeley (UC).Full story -
H1 To Incorporate Key Opinion Leader Data In Veeva CRM Platform
Sep 10, 2018, 15:12 PM by Michael CroftNEW YORK CITY, NY, UNITED STATES - Sep 10, 2018 - H1 To Incorporate Key Opinion LeaderData In Veeva CRM Platform H1 combined with Veeva CRM will help life sciences clients findFull story
the right influencers in minutes instead of months New York, NY - September 10, 2018 - H1, the first company to arm healthcare organizations with live data insights to help fight diseases, today announced that it has integrated H1's Key Opinion Leader (KOL) data solution, H1 Curie, in Veeva CRM -
Christian Marcazzo joins IDBS as Vice President and General Manager
Sep 10, 2018, 12:49 PM by Michael CroftGUILDFORD, UK - Sep 10, 2018 - Christian will be responsible for running IDBS and growing the Informatics Solutions business of the Danaher Life Sciences PlatformFull story -
XtenCHO™, the new transient expression system breaking records
Sep 10, 2018, 10:42 AM by Michael CroftSTRASBOURG, FRANCE - Sep 10, 2018 - ProteoGenix managed to develop XtenCHO™, a transient expression system outperforming the productivity of the best and most popular cell lines on the marketxFull story -
Next-Generation Knowledgebases Are Required For Interpreting Data In Precision Oncology
Sep 10, 2018, 10:25 AM by Michael CroftFull storyBio-IT World | While precision medicine has undeniably had an enormous impact on oncology and the understanding and treatment of cancer patients has improved, data interpretation still remains a significant bottleneck. To address this, The Jackson Laboratory built a Clinical Knowledgebase to provide evidence-based information to clinicians, researchers, and ultimately patients.
-
BioIVT Publishes New Research On the Mechanisms Underlying the C-DILI Assay
Sep 10, 2018, 08:21 AM by Michael CroftWESTBURY, NY, US - Sep 10, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced its research into the mechanisms involved in cholestatic drug-induced liver injury (DILI) has been published in Applied In Vitro ToxicologyFull story -
Peerwith partners with academic publisher, De Gruyter to develop collaborative peer-2-peer marketplace for authors
Sep 10, 2018, 05:09 AM by Michael CroftAMSTERDAM, NETHERLANDS - Sep 10, 2018 - Peerwith is pleased to announce a new partnership with the independent academic publisher, De Gruyter, a company with a tradition dating back to 1749Full story -
Building A SEAL Team Of Data Science Experience
Sep 6, 2018, 14:40 PM by Michael CroftFull storyBio-IT World | At the 2018 Bio-IT World Conference & Expo, we dedicated a plenary session to a panel discussion on data science. Wanting to offer the conversation to our community, we asked John Reynders about his definition of data curation, how data science methods might be misused, building a multidisciplinary team, and more.
-
BioIVT Launches Dissociated Tumor Cell (DTC) Product Line to Advance Oncology Research
Sep 6, 2018, 09:32 AM by Michael CroftWESTBURY, NY, US - Sep 6, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced the addition of a dissociated tumor cell (DTC) product line to its immunology portfolioFull story -
Certara Appoints Dr. Mark Holbrook to Lead Its Quantitative Systems Toxicology and Safety Division
Sep 5, 2018, 09:21 AM by Michael CroftPRINCETON, NJ, US - Sep 5, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today announced that it has appointed Mark Holbrook, PhD, to the newly-created position of vice president of quantitative systems toxicology and safety (QSTS)Full story -
Blood-Testing Firm Theranos To Dissolve
Sep 5, 2018, 09:14 AM by Michael CroftThe Wall Street Journal | Theranos, the blood-testing company accused of perpetrating Silicon Valley's biggest fraud, will formally dissolve. The move comes after prosecutors filed criminal charges against founder Elizabeth Holmes.Full story -
10x Genomics Acquires Epinomics, To Launch ATAC-Seq Product
Sep 5, 2018, 08:40 AM by Michael CroftFull storyBio-IT World | 10x Genomics has acquired Epinomics, a pioneer in the growing epigenetics space, giving 10x Genomics ATAC-seq technology and fundamental IP to accelerate discoveries and further research in epigenomics, paving the way for a new understanding of disease, diagnostics and therapeutics.
-
Creative Biolabs Launched Bispecific T-cell Engager for Cancer Treatment and Immune Regulation
Sep 5, 2018, 01:31 AM by Michael CroftSHIRLEY, NY - Sep 4, 2018 - Sep 4, 2018, with more than ten years of experience in serving clinical researches and academic researches, Creative Biolabs developed bispecific t cell engager for cancer treatment and immune regulation researchesFull story -
Sound Imaging’s New MRI Patient Motion Detection System Increases MRI Image Quality, Decreases Scan Times
Sep 4, 2018, 16:25 PM by Michael CroftSAN DIEGO, CA, UNITED STATE - Sep 5, 2018 - SAN DIEGO, CA — August 7, 2018 — Sound Imaging, Inc., is releasing a new patent pending MRI patient motion and movement detection system that will reduce motion artifacts, make MRI scans more efficient for imaging centers, and ensure patient comfort and safetyFull story -
Best of Show VR Winner, Nanome, Available For Free Download
Sep 4, 2018, 15:00 PM by Michael CroftBio-IT World Brief Nanome has launched its virtual reality platform for anybody interested in playing around with molecules, the company said. The platform includes a free tier on the Oculus VR Marketplace.Full story -
Key Biologics and Blood Centers of America Partner to Advance Cell Therapy and Regenerative Medicine
Sep 4, 2018, 10:57 AM by Michael CroftMEMPHIS, TN, UNITED STATES - Sep 4, 2018 - Key Biologics LLC and Blood Centers of America (BCA) today announced an agreement to formalize their existing business relationship and to work collectively to broaden support for cell therapy and regenerative medicineFull story -
Optibrium and Enamine collaboration extends commercial compound database access for StarDrop users
Sep 4, 2018, 05:12 AM by Michael CroftCAMBRIDGE AND KIEV, UKRAINE, UNITED KINGDOM - Sep 4, 2018 - Optibrium, a developer of software for drug discovery, today announced a collaboration with Enamine, a chemical research organisation and compound supplierFull story -
First CRISPR Clinical Trial Backed By US Companies Launches
Aug 31, 2018, 13:25 PM by Michael CroftSTAT | The first clinical trial of CRISPR-Cas9, co-sponsored by Vertex Pharmaceuticals, will test the genome-editing technique in patients with the blood disorder beta thalassemia.Full story -
TECHNIDATA announces the launch of a major feature of its TDBioBank software solution. The goal: Make it easier for researchers to access biological specimens thanks to the Virtual Catalog.
Aug 31, 2018, 10:24 AM by Michael CroftMONTBONNOT, FRANCE - Aug 30, 2018 - This new module enables biobanks to publish their collections of transferable biological specimens online, gain visibility and foster international scientific collaborationFull story -
Is Machine Learning Overhyped?
Aug 31, 2018, 07:42 AM by Michael CroftChemical & Engineering News | Chemists weigh in on the technique's possibilities and its pitfalls.Full story